Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.

It was first approved for short-term use only by the Federal Drug Administration (FDA) for its potential to cause cancer if prescribed in long-term use–however, Zantac® began being marketed for long-term maintenance use.

Since over-the-counter Zantac® (aka ranitidine®) contains high levels of the potentially dangerous chemical N-nitrosodimethylamine (NDMA), it has potentially linked to several types of lifelong cancers, including:

• Bladder cancer. A disease in which malignant (cancer) cells show signs and symptoms  such as blood in the urine and pain during urination.
• Esophageal cancer. A cancer that can cause difficulty swallowing, chest pain, and heartburn–tricking victims into taking more to reduce the symptoms.
• Liver cancer. Patients diagnosed with liver cancer after taking Zantac® (aka ranitidine®) typically complain of abdominal pain and swelling, plus general loss of energy.
• Pancreatic cancer. A particularly deadly form of cancer–with common symptoms that include itchy skin, yellowing of the eyes, and abdominal pain
• Stomach cancer. Also known as gastric cancer, this type of cancer forms over the course of many years–with a five-year survival rate for diagnosed individuals being 70%.

Not only that, but Zantac® should also not be taken with certain foods (or with any foods at all based on some studies) due to its potential to create carcinogenic chemicals in the body.

Zantac® and Vitamin C:

• Some studies showed that adding Vitamin C to the Zantac® formula might reduce its carcinogenic effects
• Glaxo Holdings Ltd® not only failed to add Vitamin C, they failed to warn consumers of the carcinogenic potential of the drug

Wired reveals that a 2020 study showed the Food and Drug Administration announced voluntary recalls of prescription forms of ranitidine® by two generic drug companies–Appco Pharma® and Northwind Pharmaceuticals®–bringing the total number of ranitidine® recalls to 14 in the past five months.

We believe that these victims should get the compensation and justice they deserve by addressing the makers of Zantac® (aka ranitidine®) in a court of law.